Frequency Therapeutics Operating Expenses 2011-2026 | FREQ

Annual Operating Expenses Frequency Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
128 M	94.2 M	84.5 M	59 M	98.1 M	64.5 M	49.6 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128 M	49.6 M	82.6 M

Quarterly Operating Expenses Frequency Therapeutics

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
20.3 M	28.7 M	27.6 M	-	23.3 M	24.1 M	21.5 M	-	19.1 M	18.4 M	20.1 M	-	20.3 M	21.3 M	23.3 M	-	25 M	26.9 M	24.8 M	-	16.7 M	14.7 M	12.9 M	-	25.5 M	7.02 M	5.92 M	-	5.06 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
28.7 M	5.06 M	19.7 M

Operating Expenses of other stocks in the Biotechnology industry

Issuer	Operating Expenses	Price	% 24h	Market Cap	Country
ACADIA Pharmaceuticals ACAD	708 M	$ 22.57	0.04 %	$ 3.74 B	USA
MorphoSys AG MOR	432 M	-	2.43 %	$ 254 M	Germany
Adverum Biotechnologies ADVM	140 M	-	-	$ 86.2 M	USA
Acorda Therapeutics ACOR	206 M	-	-24.86 %	$ 820 K	USA
Allakos ALLK	196 M	-	-	$ 28.6 M	USA
Akebia Therapeutics AKBA	173 M	$ 1.41	-1.4 %	$ 363 M	USA
AlloVir ALVR	46.2 M	-	4.14 %	$ 49.1 M	USA
Applied Molecular Transport AMTI	127 M	-	-	$ 10.1 M	USA
I-Mab IMAB	1.49 B	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	2.66 B	-	-	$ 40.3 B	USA
Genfit SA GNFT	78.3 M	-	2.54 %	$ 160 B	France
Applied Therapeutics APLT	74.5 M	-	-	$ 8.42 M	USA
Aravive ARAV	80 M	-	-13.39 %	$ 1.45 M	USA
Midatech Pharma plc MTP	4.78 M	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	8.22 M	-	-1.52 %	$ 24.7 M	USA
BioNTech SE BNTX	512 M	$ 91.98	-0.11 %	$ 27.2 B	Germany
Aytu BioScience AYTU	53.7 M	$ 2.56	-3.76 %	$ 16.1 M	USA
AstraZeneca PLC AZN	17.6 B	-	-	$ 96.9 B	Britain
Alterity Therapeutics Limited ATHE	16.7 M	$ 3.85	-1.39 %	$ 9.26 B	Australia
AVROBIO AVRO	71.7 M	-	1083.1 %	$ 745 M	USA
Advaxis ADXS	22 M	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	216 M	$ 20.87	2.3 %	$ 976 M	USA
Brainstorm Cell Therapeutics BCLI	31.7 M	-	-2.5 %	$ 5.88 M	USA
Aquestive Therapeutics AQST	85.5 M	$ 4.17	-0.24 %	$ 446 M	USA
Ayala Pharmaceuticals AYLA	29.8 M	-	-	$ 7.46 M	Israel
Институт стволовых клеток человека ISKJ	629 M	-	-	-	Russia
Arcutis Biotherapeutics ARQT	137 M	$ 24.57	-0.16 %	$ 3.13 B	USA
BeiGene, Ltd. BGNE	390 M	-	0.49 %	$ 251 B	Cayman-islands
Aeterna Zentaris AEZS	23 M	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	24.2 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	210 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	66.5 M	-	-	$ 26.5 M	USA
CymaBay Therapeutics CBAY	133 M	-	-	$ 3.45 B	USA
AIkido Pharma AIKI	179 M	-	1.93 %	$ 17.4 M	USA
Cabaletta Bio CABA	172 M	$ 3.17	2.59 %	$ 319 M	USA
Codiak BioSciences CDAK	92.5 M	-	-55.98 %	$ 2.15 M	USA
Aptose Biosciences APTO	24.7 M	-	-45.71 %	$ 1.2 M	Canada
Avid Bioservices CDMO	26 M	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	177 M	-	-	$ 1.41 B	USA
Can-Fite BioPharma Ltd. CANF	14 M	$ 2.93	-4.87 %	$ 6.38 B	Israel
Akero Therapeutics AKRO	80.2 M	-	-	$ 3.67 B	USA
Checkpoint Therapeutics CKPT	56.2 M	-	-	$ 169 M	USA
CureVac N.V. CVAC	88.9 M	-	-	$ 867 M	Germany
Celldex Therapeutics CLDX	58.1 M	$ 33.62	3.73 %	$ 2.23 B	USA
Concert Pharmaceuticals CNCE	110 M	-	-	$ 401 M	USA
Akari Therapeutics, Plc AKTX	17.3 M	$ 3.92	1.03 %	$ 264 B	Britain
Akouos AKUS	86.8 M	-	0.23 %	$ 488 M	USA
Celsion Corporation CLSN	14.7 M	-	-6.63 %	$ 13.9 M	USA
Allena Pharmaceuticals ALNA	47.6 M	-	3.16 %	$ 1.9 M	USA